Preview
Unable to display preview. Download preview PDF.
Abbreviations
- cAMP:
-
cyclic adenosine monophosphate
- COMT:
-
catechol O-methyl transferase
- DCI:
-
dichloroisoprenaline
- DOCA:
-
desoxycorticosterone acetate
- DOMA:
-
3,4-dihydroxymandelic acid
- DOPEG:
-
3,4-dihydroxyphenylglycol
- MAO:
-
monoamine oxidase
- MOPEG:
-
3-methoxy-4-hydroxyphenylglycol
- MN:
-
metanephrine
- NMN:
-
normetanephrine
- OMDA:
-
O-methylated and deaminated metabolites (MOPEG + VMA)
- OMI:
-
O-methyl-isoprenaline
- U-0521:
-
3,4-dihydroxy-2-methyl propiophenone
- VMA:
-
“vanillylmandelic” (3-methoxy-4-hydroxymandelic) acid
References
Åblad B, Carlsson E, Carlsson C, Dahlöf L, Holtberg E (1974) Cardiac effects of β-adrenergic receptor antagonists. Adv Cardiol 12:290–302
Abraham A (1969) Microscopic innervation of the heart and blood vessels in vertebrates including man. Pergamon, Oxford
Adler-Graschinsky E, Langer SZ (1975) Possible role of a β-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feedback mechanism. Br J Pharmacol 53:43–50
Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153:586–600
Allen GS, Glover AB, Rand MJ, Story DF (1972) Effects of acetylcholine on vasoconstriction and release of 3H-noradrenaline in response to sympathetic nerve stimulation in the isolated artery of the rabbit ear. Br J Pharmacol 46:527–528P
Allen GS, Rand MJ, Story DF (1973) Techniques for studying adrenergic transmitter release in an isolated perfused artery. Cardiovasc Res 7:423–428
Amer MS, Gomel AW, Perack JL Jr, Ferguson HC, McKinney GR (1975) Observations of cyclic nucleotide metabolism in the hearts and vessels of hypertensive rats. Proc Natl Acad Sci USA 71:4930–4934
Appenzeller O (1964) Electron microscopic study of the innervation of the auricular artery in the rat. J Anat (London) 98:87–91
Aprigliano O, Hermsmeyer K (1976) In vitro denervation of the portal vein and caudal artery of the rat. J Pharmacol Exp Ther 198:568–577
Aprigliano O, Hermsmeyer K (1977) Trophic influence of the sympathetic nervous system on the rat portal vein. Circ Res 41:198–206
Armstrong JM, Boura ALA (1973) Effects of clinidine and guanethidine on peripheral sympathetic nerve function in the pithed rat. Br J Pharmacol 47:850–852
Avakian OV, Gillespie JS (1968) Uptake of noradrenaline by adrenergic nerves, smooth muscle and connective tissue in isolated perfused arteries and its correlation with the vasoconstrictor response. Br J Pharmacol 32:168–184
Azevedo I, Osswald W (1976) Uptake, distribution and metabolism of isoprenaline in the dog saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 295:141–147
Azevedo I. Silva PS (1981) Are fibroblasts adrenergically innervated cells? Blood Vessels 18:330–332
Azevedo I, Castro-Tavares J, Garrett J (1981) Ultrastructural changes in blood vessels of perinephritic hypertensive dogs. Blood Vessels 18:110–119
Barajas L (1964) The innervation of the juxtaglomerular apparatus. An electron microscopic study of the innervation of glomerular arterioles. Lab Invest 13:916–929
Baron GD, Speden RN, Bohr DF (1972) Beta-adrenergic receptors in coronary and skeletal muscle arteries. Am J Physiol 223:878–881
Belfrage E (1978) Studies on the control of blood flow and lipolysis by α-and β-adrenoceptor in canine subcutaneous adipose tissue. Ph D Thesis, Karolinska Institute, Stockholm University
Belfrage E, Fredholm BB, Rosell S (1977) Effect of catechol-O-methyl transferase (COMT) inhibition on the vascular and metabolic responses to noradrenaline, isoprenaline and sympathetic nerve stimulation in canine subcutaneous adipose tissue. Naunyn-Schmiedeberg's Arch Pharmacol 300:11–17
Bell C (1974) Release of endogenous noradrenaline from an isolated elastic artery. J Physiol (London) 236:473–482
Bell C, Vogt M (1971) Release of endogenous noradrenaline from an isolated muscular artery. J Physiol (London) 215:509–520
Berkowitz BA, Spector S (1976) Uptake, storage and synthesis of catecholamines in blood vessels and its significance in vascular function and drug action. In: Bevan JA, Burnstock G, Johansson B, Maxwell RA, Nedergaard OA (eds) Vascular neuro-effector mechanisms. Karger, Basel, pp 102–111
Berkowitz BA, Tarver JH, Spector S (1971) Norepinephrine in blood vessels: concentration, binding, uptake and depletion. J Pharmacol Exp Ther 177:119–126
Berthelsen S, Pettinger WA (1977) A functional basis for classification of α-adrenergic receptors. Life Sci 21:595–606
Bevan JA (1977) Some functional consequences of variation, in adrenergic synaptic cleft width and in nerve density and distribution. Fed Proc 36:2439–2443
Bevan JA (1979) Some basis of differences in vascular responses to sympathetic activity. Variations on a theme. Circ Res 45:161–179
Bevan JA, Duckles SP (1975) Evidence for α-adrenergic receptors on intimal endothelium. Blood Vessels 12:307–310
Bevan JA, Osher JV (1965) Relative sensitivity of some large blood vessels of the rabbit to sympathomimetic amines. J Pharmacol Exp Ther 150:370–374
Bevan JA, Osher JV (1970) Distribution of norepinephrine released from adrenergic motor terminals in arterial wall. Eur J Pharmacol 13:55–58
Bevan JA, Purdy RE (1973) Variations in adrenergic innervation and contractile responses of the rabbit saphenous artery. Circ Res 32:746–751
Bevan JA, Su C (1973) Sympathetic mechanisms in blood vessels: nerve and muscle relationships. Ann Rev Pharmacol 13:269–285
Bevan JA, Török J (1970) Movement of norepinephrine through the media of rabbit aorta. Circ Res 27:325–331
Bevan JA, Bevan RD, Purdy RE, Robinson CP, Su C, Waterson JG (1972) Comparison of adrenergic mechanisms in an elastic and a muscular artery of the rabbit. Circ Res 30:541–548
Bevan JA, Pegram BL, Prehn JL, Winquist RJ (1978) Beta-adrenergic receptor mediated vasodilatation. In: Vanhoutte PM, Leusen I (eds) Mechanisms of vasodilatation. Karger, Basel, pp 258–265
Bevan JA, Bevan RD, Duckles SP (1980a) Adrenergic regulation of vascular smooth muscle. In: Bohr DF, Somlyo AP, Sparks HV Jr (eds) Vascular smooth muscle. American Physiological Society, Bethesda (Handbook of physiology, vol II, sect 2, pp 515–566)
Bevan JA, Godfraind T, Maxwell RA, Vanhoutte PM (1980b) Vascular neuroeffector mechanisms. Chapter 12: Disposition of norepinephrine in the blood vessel wall. Raven, New York, pp 147–180
Bevan RD (1975) Effect of sympathetic denervation on smooth muscle cell proliferation in the growing rabbit ear artery. Circ Res 37:14–19
Bevan RD, Tsuru H (1979a) Long term denervation of vascular smooth muscle causes not only functional but structural change. Blood Vessels 16:109–112
Bevan RD, Tsuru H (1979b) The trophic effect of the sympathetic neuron on the artery wall in growing rabbits. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: basic and clinical frontiers. Pergamon, New York, pp 465–467
Bevan RD, Tsuru H (1980) Changes in the tunica media of the rabbit ear artery after denervation are age-related. In: Bevan JA, Godfraind T, Maxwell RA, Vanhoutte PM (eds) Vascular neuroeffector mechanisms. Raven, New York, pp 119–123
Bieth N, Rouot B, Schwartz J, Velly J (1980) Comparison of pharmacological and binding assays for ten β-adrenoceptor blocking agents and two β-adrenoceptor agonists. Br J Pharmacol 68:563–569
Bloom FE (1972) Electron microscopy of catecholamine-containing structures. In: Blaschko H, Muscholl E (eds) Catecholamines. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 33, pp 46–105)
Bönisch H (1981) The role of sodium in the indirect effects of sympathomimetic amines. Proceedings of the 4th Meeting Adrenergic Mechanisms, University of Porto, Porto, p 137
Bönisch H, Uhlig W, Trendelenburg U (1974) Analysis of the compartments involved in the extraneuronal storage and metabolism of isoprenaline in the perfused heart. Naunyn-Schmiedeberg's Arch Pharmacol 283:233–244
Bohr DF (1967) Adrenergic receptors in coronary arteries. Ann NY Acad Sci 139:799–807
Bonaccorsi A, Jespersen J, Garattini S (1970) The influence of desipramine on the sensitivity and accumulation of noradrenaline in the isolated tail artery. Eur J Pharmacol 9:124–127
Booz KH (1971) Zur Innervation der autonom pulsierenden Vena porta der weissen Ratte. Eine histochemische und elektronenmikroskopische Untersuchung. Z Zellforsch Anat 117:394–418
Borowski E, Ehrl H, Starke K (1976) Relative pre-and postsynaptic potencies of α-adrenolytic drugs. Naunyn-Schmiedeberg's Arch Pharmacol 293:R2
Branco D, Osswald W (1980) The fate of isoprenaline after inhibition of O-methylation and of extraneuronal uptake. Eur J Pharmacol 67:247–253
Branco D, Azevedo I, Sarmento A, Osswald W (1981a) The fate of isoprenaline in the isolated rabbit aorta. Radiochemical and morphologic observations. Naunyn-Schmiedeberg's Arch Pharmacol 316:120–125
Branco D, Azevedo I, Teixeira AA, Osswald W (1981b) Influence of sympathetic denervation on extraneuronal mechanisms of saphenous vein. Proceedings 4th Meeting Adrenergic Mechanisms, University of Porto, Porto, p 179
Brandão F (1976) A comparative study of the role played by some inactivation pathways in the disposition of the transmitter in the rabbit aorta and the saphenous vein of the dog. Blood Vessels 13:309–318
Brandão F (1977) Inactivation of norepinephrine in an isolated vein. J Pharmacol Exp Ther 203:23–29
Brandão F (1979) Inactivation of the sympathetic transmitter in a vascular structure (in Portuguese). Ph D Thesis, University of Porto
Brandão F, Guimarães S (1974) Inactivation of endogenous noradrenaline released by electrical stimulation in vitro of dog saphenous vein. Blood Vessels 11:45–54
Brandão F, Monteiro JG, Osswald W (1978) Differences in the metabolic fate of noradrenaline released by electrical stimulation or by tyramine. Naunyn-Schmiedeberg's Arch Pharmacol 305:37–40
Brandão F, Paiva MQ, Guimarães S (1980a) The role of neuronal and extraneuronal systems in the metabolism of adrenaline and noradrenaline released from nerve terminals by electrical stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 311:1–7
Brandão F, Rodrigues-Pereira E, Monteiro JG, Osswald W (1980b) Characteristics of tyramine induced release of noradrenaline: mode of action of tyramine and metabolic fate of the transmitter. Naunyn-Schmiedeberg's Arch Pharmacol 311:9–15
Brandão F, Rodrigues-Pereira E, Monteiro JG, Davidson R (1981) A kinetic study of the release of noradrenaline by tyramine. Naunyn-Schmiedeberg's Arch Pharmacol 318:83–87
Brodde OE, Gross G (1980) 3H-spiroperidol labels dopamine receptors in membranes from rabbit mesenteric artery. Naunyn-Schmiedeberg's Arch Pharmacol 311:249–253
Brown GL, Gillespie JS (1957) The output of sympathetic transmitter from the spleen of the cat. J Physiol (London) 138:81–102
Brown MJ, Macquin I (1981) Is adrenaline the cause of essential hypertension? Lancet 2:1079–1082
Bryan LJ, O'Donnell SR (1979) Comparison of the effects of tropolone, β-thujaplicin and U-0521 on the extraneuronal accumulation of isoprenaline in guinea-pig trachealis smooth muscle cells. Naunyn-Schmiedeberg's Arch Pharmacol 307:235–241
Bryan LJ, Cole JJ, O'Donnell SR, Wanstall JC (1981) A study designed to explore the hypothesis that beta-1 adrenoceptors are “innervated” receptors and beta-2 adrenoceptors are “hormonals” receptors. J Pharmacol Exp Ther 216:395–400
Burnstock G (1975) Innervation of vascular smooth muscle: histochemistry and electron microscopy. Clin Exp Pharmacol Physiol [Suppl] 2:7–20
Burnstock G, Costa M (1975) Adrenergic neurons: their organization, function and development in the peripheral nervous system. Chapman & Hall, London
Burnstock G, Gannon BJ, Iwayama T (1970) Sympathetic innervation of vascular muscle in normal and hypertensive animals. Circ Res 27 [Suppl II]: 5–24
Burnstock G, McCulloch MW, Story DF, Wright ME (1972) Factors affecting the extraneuronal inactivation of noradrenaline in cardiac and smooth muscle. Br J Pharmacol 46:243–253
Burri PH, Weibel ER (1968) Beeinflussung einer spezifischen cytoplasmatischen Organelle von Endothelzellen durch Adrenalin. Z Zellforsch 88:426–440
Caramona M (1982) Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog. Naunyn-Schmiedeberg's Arch Pharmacol (in press)
Carlsson E, Åblad B, Brandstrom A, Carlsson B (1972) Differential blockade of the chronotropic effects of various adrenergic stimuli in the cat heart. Life Sci 11:953–958
Cavero I, Dennis T, Lefèvre-Borg F, Perrot P, Roach AG, Scatton B (1979) Effects of clonidine, prazosin and phentolamine on heart rate and coronary sinus catecholamine concentration during cardioaccelerator nerve stimulation in spinal dogs. Br J Pharmacol 67:283–292
Céch S, Dolezel S (1967) Monoaminergic innervation of the pulmonary vessels in various laboratory animals (rat, rabbit, cat). Experientia 23:114–115
Celander O, Mellander S (1955) Elimination of adrenaline and noradrenaline from the circulating blood. Nature (London) 176:973–974
Celuch SM, Dubocovich ML, Langer SZ (1978) Stimulation of presynaptic β-adrenoceptors enhances 3H-noradrenaline release during nerve stimulation in the perfused cat spleen. Br J Pharmacol 63:97–109
Chamley JH, Dowell JJ (1975) Specificity of nerve fiber “attraction” to autonomic effector organs in tissue culture. Exp Cell Res 90:1–7
Chubb IW, de Potter WP, de Schaepdryver AF (1972) Tyramine does not release noradrenaline from splenic nerve by exocytosis. Naunyn-Schmiedeberg's Arch Pharmacol 274:281–286
Cliff WJ (1976) Blood vessels. Cambridge University Press, Cambridge
Cohen ML, Berkowitz B (1976) Decreased vascular relaxation in hypertension. J Pharmacol Exp Ther 196:396–406
Cohen ML, Wiley KS (1978) Beta1 and beta2 receptor mechanisms in the rat jugular vein: differences between norepinephrine and isoproterenol-induced relaxation. Life Sci 23:1997–2006
Coimbra A, Ribeiro-Silva A, Osswald W (1974) Fine structural and autoradiographic study of the adrenergic innervation of the dog lateral saphenous vein. Blood Vessels 11:128–144
Constantine JW, Lebel W (1980) Complete blockade by phenoxybenzamine of α 1-but not α 2-vascular receptors in dogs and the effects of propranolol. Naunyn-Schmiedeberg's Arch Pharmacol 314:149–156
Constantine JW, Weeks RA, McShane WK (1978) Prazosin and presynaptic α-receptors in the cardioaccelerator nerve of the dog. Eur J Pharmacol 50:51–60
Dahlöf C, Åblad B, Borg KO, Ek L, Waldeck B (1975) Prejunctional inhibition of adrenergic nervous vasomotor control due to β-receptor blockade. In: Almgren O, Carlsson A, Engel J (eds) Chemical tools in catecholamine research, vol II. North-Holland, Amsterdam, pp 201–210
Dahlöf C, Ljung B, Åblad B (1978) Increased noradrenaline release in rat portal vein during sympathetic nerve stimulation. Eur J Pharmacol 50:75–78
Dahlöf C, Ljung B, Åblad B (1980) Pre-and postjunctional beta-adrenoceptor mediated effects on transmitter release and effector response in the isolated rat portal vein. Acta Physiol Scand 108:39–47
Dahlöf C, Eriksson BM, Hjemdahl P, Åblad B (1981) Tissue contents and plasma levels of catecholamines after adrenal demedulation, chemical sympathectomy or inhibition of PNMT in rat (SHR). In: Proceedings 4th Meeting Adrenergic Mechanisms, University or Porto, Porto, p 96
Dahlström A, Häggendahl J (1973) Heterogeneity of amine storage particles and the possible relation to different pools of transmitter. In: Proceedings 2nd Meeting Adrenergic Mechanisms, University of Porto, Porto, p 18
De la Lande IS (1975) Adrenergic mechanisms in the rabbit ear artery. Blood Vessels 12:137–160
De la Lande IS (1981) Inactivation and metabolism of catecholamines. Proceedings 4th Meeting Adrenergic Mechanisms, University of Porto, Porto, pp 75–91
De la Lande IS, Jellet LB (1972) Relationship between the role of monoamine oxidase and sympathetic nerves in the vasoconstrictor response of the rabbit ear artery to norepinephrine. J Pharmacol Exp Ther 180:47–55
De la Lande IS, Frewin D, Waterson JG (1967) The influence of sympathetic innervation on vascular sensitivity to noradrenaline. Br J Pharmacol 31:82–93
De la Lande IS, Hodge RL, Lazner MA, Jellet LB, Waterson JG (1970) Pharmacological implications of the fate of noradrenaline in the artery wall. Circ Res 26/27 [Suppl 2]:41–48
De la Lande IS, Harvey JA, Holt S (1974) Response of the rabbit coronary arteries to autonomic agents. Blood Vessels 11:319–337
De la Lande IS, Parker DAS, Morris R, Irvine R, Graefe K-H (1980) Noradrenaline diffusion across the artery. In: Bevan JA, Godfraind T, Maxwell RA, Vanhoutte PM (eds) Vascular neuroeffector mechanisms. Raven, New York, pp 148–160
De Mey JG, Vanhoutte PM (1980) Differences of pharmacological properties of post-junctional alpha-adrenergic receptors among arteries and veins. Arch Int Pharmacodyn 244:328–329
De Potter WP, Chubb IW (1971) The turnover rate of noradrenergic vesicles. Biochem J 125:375–376
De Potter WP,de Schaepdryver AF, Moerman EJ, Smith AD (1969) Evidence for the release of vesicle-proteins together with noradrenaline upon stimulation of the splenic nerve. J Physiol (London) 204:102–104P
Devine CE, Simpson FO (1967) The fine structure of vascular sympathetic neuromuscular contacts in the rat. Am J Anat 121:153–174
Docherty JR, McGrath JC (1979) An analysis of some factors influencing α-adrenoceptor feed-back at the sympathetic junction in the heart. Br J Pharmacol 66:55–63
Docherty JR, Starke K (1981) Postsynaptic α-adrenoceptor subtypes mediating nerveevoked contractions in rabbit blood vessels in vitro. Br J Pharmacol 74:803P
Docherty JR, MacDonald A, McGrath JC (1979) Further sub-classification of α-adrenoceptors in the cardiovascular system, vas deferens and anococcygeus of the rat. Br J Pharmacol 67:421–422P
Dolezel S (1972) Monoaminergic innervation of aorta. Folia Morphol 20:14–20
Doxey JC, Everitt J (1977) Inhibitory effects of clonidine on responses to sympathetic nerve stimulation in the pithed rat. Br J Pharmacol 61:559–566
Drew GM, Whiting SB (1979) Evidence for two distinct types of postsynaptic α-adrenoceptors in vascular smooth muscle in vivo. Br J Pharmacol 67:207–215
Dubocovich ML, Langer SZ (1974) Negative feedback regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: differences in potency of phenoxybenzamine in blocking the pre-and post-synaptic receptors. J Physiol (London) 237:505–519
Dubocovich ML, Langer SZ (1976) Influence of the frequency of nerve stimulation on the metabolism of 3H-norepinephrine released from the perfused cat spleen: differences observed during and after the period of stimulation. J Pharmacol Exp Ther 198:83–101
Duckles SP (1980) Functional activity of the noradrenergic innervation of large cerebral arteries. Br J Pharmacol 69:193–199
Duckles SP, Rapaport R (1979) Release of endogenous norepinephrine from a rabbit cerebral artery. J Pharmacol Exp Ther 211:219–224
Eckert E, Henseling M, Gescher A, Trendelenburg U (1976a) Stereo-selectivity of the distribution of labelled noradrenaline in rabbit aortic strips after inhibition of the noradrenaline metabolizing enzymes. Naunyn-Schmiedeberg's Arch Pharmacol 292:219–229
Eckert E, Henseling M, Trendelenburg U (1976b) The effect of inhibitors of extraneuronal uptake on the distribution of 3H-(±)-noradrenaline in nerve-free rabbit aortic strips. Naunyn-Schmiedeberg's Arch Pharmacol 293:115–127
Edvinsson L, Owman C (1974) Pharmacological characterization of adrenergic alpha and beta receptors mediating vasomotor response of cerebral arteries in vitro. Circ Res 35:835–849
Ehinger B, Falck B, Sporrong B (1967) Adrenergic fibers to the heart and to peripheral vessels. Bibl Anat 8:35–47
Endo T, Starke K, Bangerter A, Taube HD (1977) Presynaptic receptor system on the noradrenergic neurons of the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 296:229–247
Fain JN, Garcia-Sainz JA (1978) Role of phosphatidylinositol turnover in alpha1 and of adenylate cyclase inhibition in alpha2 effects of catecholamines. Life Sci 26:1183–1194
Farnebo L-O, Hamberger B (1971) Drug-induced changes in the release of 3H-noradrenaline from field stimulated rat iris. Br J Pharmacol 43:97–106
Fillenz M (1970) Innervation of pulmonary and bronchial blood vessels of the dog. J Anat (London) 106:449–461
Fillenz M, West DP (1976) Fate of noradrenaline storage vesicles after release. Neurosci Lett 2:285–287
FitzGerald GA, Watkins J, Dollery CT (1981) Regulation of norepinephrine release by peripheral α 2-receptor stimulation. Clin Pharmacol Ther 29:160–167
Flavahan NA, McGrath JC (1981) An analysis of α 1-and α 2-adrenoceptor mediated pressor effects of adrenaline. Br J Pharmacol 72:519P
Folkow B, Neil E (1971) Circulation. Oxford University Press, New York
Franco-Morselli R, Elghozi JL, Joly E, di Giulio S, Meyer P (1977) Increased plasma adrenaline in benign essential hypertension. Br Med J 2:1251–1254
Fredholm BB, Rosell S (1968) Effects of adrenergic blocking agents on lipid mobilization from canine subcutaneous adipose tissue after sympathetic nerve stimulation. J Pharmacol Exp Ther 159:1–7
Fried G, Lagercrantz H, Hökfelt T (1979) Small noradrenergic vesicles from vas deferens of castrated rats: a comparison with large noradrenergic vesicles. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: basic and clinical frontiers. Pergamon, New York, pp 349–351
Furchgott RF (1967) The pharmacological differentiation of adrenergic receptors. Ann NY Acad Sci 139:553–570
Furchgott RF (1973) Interactions of drugs at the receptor level. In: Proceedings 2nd Meeting Adrenergic Mechanisms, University of Porto, Porto, pp 79–89
Furchgott RF (1976) Postsynaptic adrenergic receptor mechanisms in vascular smooth muscle. In: Bevan JA, Burnstock G, Johansson B, Maxwell RA, Nedergaard OA (eds) Vascular neuroeffector mechanisms. Karger, Basel, pp 131–142
Furchgott RF, Sanchez-Garcia P (1968) Effects of inhibition of monoamine oxidase on the actions and interactions of norepinephrine, tyramine and other drugs on guinea-pig left atrium. J Pharmacol Exp Ther 163:98–122
Garrett J, Branco D (1977) Uptake and metabolism of noradrenaline by the mesenteric arteries of the dog. Blood Vessels 14:43–54
Garrett J, Branco D (1978) Different behaviour of endogenous noradrenaline in two vessels of the dog. In: Azevedo I, Guimarães S, Moura D, Paiva MQ (eds) Proceedings 3th Meeting Adrenergic Mechanisms, University of Porto, Porto, p 69
Garrett J, Malafaya-Baptista A, Osswald W (1966) Effects of pronethalol on the cardiovascular actions of catecholamines during blockade by phenoxybenzamine. Br J Pharmacol 27:459–467
Geffen LB, Livett BG, Rush RA (1969) Immunological localization of chromogranins in sheep sympathetic neurones and their release by nerve impulse. J Physiol (London) 204:58–59P
Gero J, Gerova M (1971) In vivo studies of sympathetic control of vessels of different functions. In: Bevan JA, Furchgott RF, Maxwell RA, Somlyo AP (eds) Physiology and pharmacology of vascular neuroeffector systems. Karger, Basel, pp 86–94
Gillespie JS (1976) Extraneuronal uptake of catecholamines in smooth muscle and connective tissue. In: Paton DM (ed) The mechanism of neuronal and extraneuronal transport of catecholamines. Raven, New York, pp 325–354
Gillis CN (1971) Inactivation of norepinephrine released by electrical stimulation of rabbit aorta in a gaseous medium. In: Bevan JA, Furchgott RF, Maxwell RA, Somlyo AP (eds) Physiology and pharmacology of vascular neuroeffector systems. Karger, Basel, pp 47–52
Gillis CN (1980) Metabolism of vasoactive hormones by pulmonar vascular endothelium: possible functional significance. In: Bevan JA, Godfraind T, Maxwell RA, Vanhoutte PM (eds) Vascular neuroeffector mechanisms. Raven, New York, pp 304–314
Gillis CN, Roth JA (1976) Pulmonary disposition of vasoactive hormones. Biochem Pharmacol 25:2547–2553
Glaubiger G, Tsai BS, Lefkowitz RJ, Weiss B, Johnson EM Jr (1978) Chronic guanethidine treatment increases cardiac β-adrenergic receptors. Nature (London) 273:240–241
Glick G, Epstein SE, Wechsler AS, Braunwald E (1967) Physiological differences between the effects of neuronally released and bloodborn norepinephrine on beta adrenergic receptors in the arterial bed of the dog. Circ Res 21:217–227
Goldberg LI, Toda N (1975) Dopamine induced relaxation of isolated canine renal, mesenteric and femoral arteries contracted with prostaglandin F2α. Circ Res 36 [Suppl I]: 97–102
Goldberg LI, Yeh BK (1969) Specific block of dopamine receptors in the renal vascular bed by chlorpromazine. In: 4th Int Congr Pharmacol (Abstr), p 359
Goldberg LI, Volkman PH, Kohli JD (1978) A comparison of the vascular dopamine receptor with other dopamine receptors. Ann Rev Pharmacol Toxicol 18:57–79
Gryglewski R, Vane JR (1970) The inactivation of noradrenaline and isoprenaline in dogs. Br J Pharmacol 39:573–584
Guimarães S (1969) Alpha excitatory, alpha inhibitory and beta inhibitory adrenergic receptors in the guinea-pig stomach. Arch Int Pharmacodyn 179:188–201
Guimarães S (1975) Further study of the adrenoceptors of the saphenous vein of the dog: influence of factors which interfere with the concentrations of agonists at the receptor level. Eur J Pharmacol 34:9–19
Guimarães S (1982) Two adrenergic biophases in blood vessels. Trends in Pharmacological Sciences 3:159–161
Guimarães S, Brandão F (1973) Comparison between the effects produced by chronic denervation and by cocaine on the sensitivity to and on the disposition of noradrenaline in isolated spleen strips. Naunyn-Schmiedeberg's Arch Pharmacol 277:163–174
Guimarães S, Paiva MQ (1977a) Differential influence of block of catechol-O-methyl transferase (COMT) activity and of neuronal uptake on α-and β-adrenergic effects. J Pharm Pharmacol 29:502–503
Guimarães S, Paiva MQ (1977b) The role played by extraneuronal system in the disposition of noradrenaline and adrenaline in vessels. Naunyn-Schmiedeberg's Arch Pharmacol 296:279–287
Guimarães S, Paiva MQ (1981a) Are β-agonists able to occupy β-adrenoceptors without causing effect? A study on the saphenous vein of the dog. In: Proceedings 4th Meeting Adrenergic Mechanisms, University of Porto, Porto, p 37
Guimarães S, Paiva MQ (1981b) Two distinct adrenoceptor-biophases in the vasculature: one for α-and the other for β-agonists. Naunyn-Schmiedeberg's Arch Pharmacol 316:195–199
Guimarães S, Paiva MQ (1981c) Two different biophases for adrenaline released by electrical stimulation or tyramine from the sympathetic nerve endings of the dog saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 316:200–204
Guimarães S, Azevedo I, Cardoso W, Oliveira MC (1975) Relation between the amount of smooth muscle of venous tissue and the degree of supersensitivity to isoprenaline caused by inhibition of catechol-O-methyl transferase. Naunyn-Schmiedeberg's Arch Pharmacol 286:401–412
Guimarães S, Brandão F, Paiva MQ (1978) A study of the adrenoceptor-mediated feedback mechanisms by using adrenaline as a false transmitter. Naunyn-Schmiedeberg's Arch Pharmacol 305:185–188
Guimarães S, Paiva MQ, Moura D (1982) Evidence for the existence of distinct biophases for α-and β-adrenoceptors in the vascular tissue. J Cardiovasc Pharmacol 4 [Suppl I]:58–62
Gulati OD, Gokhale SD, Udwadia BP (1965) Antagonism of adrenergic blockade by pronethalol. Arch Int Pharmacodyn 156:389–397
Guth L (1968) “Trophic” influences of nerve on muscle. Physiol Rev 48:645–687
Gutmann E (1976) Neurotrophic relations. Ann Rev Physiol 38:177–216
Hamberger B, Norberg KA, Olson L (1967) Extraneuronal binding of catecholamines and 3,4-dihydroxyphenylalanine (dopa) in salivary glands. Acta Physiol Scand 69:1–12
Hamilton CA, Reid JL (1980) Postsynaptic location of α 2-adrenoceptors in vascular smooth muscle. Br J Pharmacol 70:63P
Hamilton CA, Reid JL (1981) The effect of 6-hydroxydopamine on rabbit peripheral alpha adrenoceptors in vivo and in vitro. Br J Pharmacol 72:119P
Hamilton FN, Fiegl EO (1976) Coronary vascular sympathetic beta-receptor innervation. Am J Physiol 230:1569–1576
Hancock A, DeLean AL, Lefkowitz RJ (1979) Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique. Mol Pharmacol 16:1–9
Hartman BK (1973) The innervation of cerebral blood vessels by central noradrenergic neurons. In: Usdin E, Snyder SH (eds) Frontiers in catecholamine research. Pergamon, New York, pp 91–96
Häusler G (1975) The importance of the presynaptic α-adrenergic regulation of noradrenaline release from vascular nerves in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 287:R19
Head RJ, Stitzel RE, De la Lande IS, Johnson SM (1977) The effect of chronic denervation on the activities of monoamine oxidase and catechol-O-methyl transferase and on the contents of noradrenaline and adenosine triphosphate in the rabbit ear artery. Blood Vessels 14:229–239
Head RJ, De la Lande IS, Irvine RJ, Johnson SM (1980) Uptake and O-methylation of isoprenaline in the rabbit ear artery. Blood Vessels 17:229–245
Head RJ, Hempstead J, Berkowitz BA (1982) Catecholamines in the vasculature of the rat and rabbit: dopamine, norepinephrine, epinephrine. Blood Vessels 19:135–147
Hedqvist P (1974) Effect of prostaglandins and prostaglandin synthesis inhibitors on norepinephrine release from vascular tissue. In: Robinson HJ, Vane JR (eds) Prostaglandin synthetase inhibitors. Raven, New York, pp 303–309
Hedqvist P, Fredholm BB (1976) Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement. Naunyn-Schmiedeberg's Arch Pharmacol 293:217–223
Henseling M (1978) Contribution by neuronal and extraneuronal mechanisms to the elimination of noradrenaline from the extracellular space (rabbit aorta). Naunyn-Schmiedeberg's Arch Pharmacol 302:R50
Henseling M (1980) Distribution and metabolic fate of 3H-noradrenaline in rabbit aorta and their influence on muscle contraction. In: Bevan JA, Godfraind T, Maxwell RA, Vanhoutte PM (eds) Vascular neuroeffector mechanisms. Raven, New York, pp 160–170
Henseling M (1981) The effect of inhibition of uptake2 on the stimulation-evoked overflow of noradrenaline in the rabbit aorta. Naunyn-Schmiedeberg's Arch Pharmacol 316:R54
Henseling M, Trendelenburg U (1978) Stereoselectivity of the accumulation and metabolism of noradrenaline in rabbit aortic strips. Naunyn-Schmiedeberg's Arch Pharmacol 302:195–206
Henseling M, Eckert E, Trendelenburg U (1976a) The distribution of 3H-(±)-noradrenaline in rabbit aortic strips after inhibition of the noradrenaline-metabolizing enzymes. Naunyn-Schmiedeberg's Arch Pharmacol 292:205–217
Henseling M, Eckert E, Trendelenburg U (1976b) The effect of cocaine on the distribution of labelled noradrenaline in rabbit aortic strips and on efflux of radioactivity from the strips. Naunyn-Schmiedeberg's Arch Pharmacol 292:231–241
Hermsmeyer K, Aprigliano O (1980) Cellular mechanisms of the neurotrophic influence in vascular muscle. In: Bevan JA, Godfraind T, Maxwell RA, Vanhoutte PM (eds) Vascular neuroeffector mechanisms. Raven, New York, pp 113–119
Hertting G (1964) The fate of 3H-isoproterenol in the rat. Biochem Pharmacol 13:1119–1128
Hirst GDS, Neild TO (1980) Evidence for two populations of excitatory receptors for noradrenaline on arteriolar smooth muscle. Nature (London) 283:767–768
Hoffbrand BI, Forsyth RP (1973) Regional blood flow changes during norepinephrine, tyramine and methoxamine infusions in the unanesthetized Rhesus monkey. J Pharmacol Exp Ther 184:656–661
Hoffman BB, Lefkowitz RJ (1980) Radioligand binding studies of adrenergic receptors: new insights into molecular and physiological regulations. Ann Rev Pharmacol Toxicol 20:581–608
Hoffman BB, De Lean A, Wood CL, Schocken DD (1979) Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. Life Sci 24:1739–1745
Holman ME (1969) Electrophysiology of vascular smooth muscle. Ergebn Physiol 61:137–177
Holman ME, Karby CB, Suthers MB, Wilson JAF (1968) Some properties of the smooth muscle of rabbit portal vein. J Physiol (London) 196:111–132
Holtz P, Credner K (1942) Die enzymatische Entstehung von Oxytyramin im Organismus und die physiologische Bedeutung der Dopadecarboxylase. Naunyn-Schmiedebergs Arch Exp Pathol Pharmakol 200:356–388
Holtz P, Heise R, Lüdtke K (1938) Fermentativer Abbau von L-Dioxyphenylalanin (DOPA) durch die Niere. Naunyn-Schmiedebergs Arch Exp Pathol Pharmakol 191:87–118
Holtz P, Stock K, Westermann E (1963) Über die Blutdruckwirkung des Dopamin. Naunyn-Schmiedebergs Arch Exp Pathol Pharmakol 246:133–146
Holtz P, Stock K, Westermann E (1964) Pharmakologie des Tetrahydropapaverolins und seine Entstehung aus Dopamin. Naunyn-Schmiedebergs Arch Exp Pathol Pharmakol 248:387–405
Holzbauer M, Sharman DF (1972) The distribution of catecholamines in vertebrates. In: Blaschko H, Muscholl E (eds) Catecholamines. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 33, pp 111–185)
Hornykiewicz O (1958) The action of dopamine on the arterial pressure of the guinea pig. Br J Pharmacol 13:91–94
Hughes J (1972) Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol 44:472–491
Hughes J, Roth RH (1969) Enhanced release of transmitter during sympathetic nerve stimulation in the presence of angiotensin. Br J Pharmacol 37:516–517P
Hughes J, Roth RH (1974) Variation in noradrenaline output with changes in stimulus frequency and train length: the role of different noradrenaline pools. Br J Pharmacol 51:373–381
Hui KKP, Conolly ME (1981) Increased numbers of beta receptors in orthostatic hypotension due to autonomic dysfunction. N Engl J Med 304:1473–1476
Hume WR (1973) Cholinergic factors in the maintenance of vascular tone. Ph D Thesis, University of Adelaide
Ikeda M (1970) Adrenergic innervation of the ductus arteriosus of the fetal lamb. Experientia 26:525–526
Iversen LL (1967) The uptake and storage of noradrenaline in sympathetic nerves. Cambridge University Press, Cambridge
Iversen LL (1971) Role of transmitter uptake in synaptic neurotransmission. Br J Pharmacol 41:571–591
Jakobs KH (1979) Inhibition of adenylate cyclase by hormones and neurotransmitters. Mol Cell Pharmacol 16:147–156
Jakobs KH, Saur W, Schultz G (1978) Inhibition of platelet adenylate cyclase by epinephrine requires GTP. FEBS Lett 85:167–170
Jarrott B, Langer SZ (1971) Changes in monoamine oxidase and catechol-O-methyl transferase activities after denervation of the nictitating membrane of the cat. J Physiol (London) 212:549–559
Junod AF (1975) Metabolism, production and release of hormones and mediators in the lung. Am Rev Respir Dis 112:93–108
Kalsner S (1972) Differential activation of the inner and outer muscle cell layers of the rabbit ear artery. Eur J Pharmacol 20:122–124
Kalsner S (1975) Role of extraneuronal mechanisms in the termination of contractile responses to amines in the vascular tissue. Br J Pharmacol 53:267–277
Kalsner S (1976) The lack of effect of oxytetracycline on responses to sympathetic nerve stimulation and catecholamines in vascular tissues. Br J Pharmacol 58:261–266
Kalsner S (1977) Termination of effector responses to agonists: an analysis of agonist disposition mechanisms. Can J Pharmacol 55:316–330
Kalsner S (1979a) Single pulse stimulation of guinea-pig vas deferens and the presynaptic receptor hypothesis. Br J Pharmacol 66:343–349
Kalsner S (1979b) Termination of agonist action on autonomic receptor. In: Kalsner S (ed) Trends in autonomic pharmacology, vol I. Urban & Schwarzenberg, Baltimore, pp 265–287
Kalsner S, Nickerson M (1969) Disposition of norepinephrine and epinephrine in vascular tissue by the technique of oil immersion. J Pharmacol Exp Ther 165:152–165
Keatinge WR (1966) Electrical and mechanical responses of arteries to stimulation of sympathetic nerves. J Physiol (London) 185:701–715
Keatinge WR, Torrie C (1976) Action of sympathetic nerves on inner and outer muscle of sheep carotid artery, and effect of pressure on nerve distribution. J Physiol (London) 257:699–712
Kebabian JW, Cote TE (1981) Dopamine receptor and cyclic AMP: a decade of progress. Trends in Pharmacological Sciences 2:69–71
Kenakin TP (1980) On the influence of agonist concentration-gradients within isolated tissues. Increased maximal responses of rat vasa deferentia to (—)-noradrenaline after blockade of neuronal uptake. J Pharm Pharmacol 32:833–838
Kirpekar SM, Puig M (1971) Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine. Br J Pharmacol 43:359–369
Kobinger W, Pichler L (1980) Investigation into different types of post-and presynaptic α-adrenoceptors at cardiovascular sites in rats. Eur J Pharmacol 65:393–402
Kobinger W, Lillie C, Pichler L (1980) Central cardiovascular α-adrenoceptors. Relation to peripheral receptors. Circ Res [Suppl] 67:I12–I25
Kurahashi K, Rawlow A, Trendelenburg U (1980) A mathematical model representing the extraneuronal O-methylating system of the perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 311:17–32
Lands AM, Luduena FP, Buzzo HJ (1967a) Differentiation of receptors responsive to isoproterenol. Life Sci 6:2241–2249
Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG Jr (1967b) Differentiation of receptor systems activated by sympathomimetic amines. Nature (London) 214:597–598
Lang J (1974) Feinstruktur der Arterienwände. Verh Dtsch Ges Kreislaufforsch 40:1–14
Langer SZ (1970) The metabolism of 3H-noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat. J Physiol (London) 208:515–546
Langer SZ (1973) The regulation of transmitter release elicited by nerve stimulation through a presynaptic feedback mechanism. In: Usdin E, Snyder S (eds) Frontiers in catecholamine research. Pergamon, New York, pp 543–549
Langer SZ (1974a) Presynaptic regulation of catecholamine release. Biochem Pharmacol 23:1793–1800
Langer SZ (1974b) Selective metabolic pathways for noradrenaline in the peripheral and in the central nervous system. Med Biol 57:372–383
Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60:481–497
Langer SZ (1979) Presynaptic adrenoceptors and regulation of release. In: Paton DM (ed) The release of catecholamines from adrenergic neurons. Pergamon, New York, pp 59–85
Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337–362
Langer SZ, Enero MA (1974) The potentiation of responses to adrenergic nerve stimulation in the presence of cocaine: its relationship to the metabolic fate of released norepinephrine. J Pharmacol Exp Ther 191:431–443
Langer SZ, Shepperson NB (1981a) Evaluation of the selectivity of M-7 for α1 and α2-adrenoceptors in vitro. Br J Pharmacol 74:841P
Langer SZ, Shepperson NB (1981b) Antagonism of alpha-adrenoceptor mediated contractions of the isolated saphenous vein of the dog by diltiazem and verapamil. Br J Pharmacol 74:942P
Langer SZ, Adler E, Enero MA, Stefano FJE (1971) The role of alpha receptor in regulating noradrenaline overflow by nerve stimulation. In: Proceedings XXVth International Congress of Physiological Sciences. Munich, p 335
Langer SZ, Enero MA, Adler-Graschinsky E, Dubocovich ML, Celuch SM (1975) Presynaptic regulatory mechanisms for noradrenaline release by nerve stimulation. In: Davies DS, Reid JL (eds) Central action of drugs in blood pressure regulation. Pitman Medical, London, pp 133–150
Langer SZ, Massingham R, Shepperson NB (1981) Differential sensitivity to prazosin blockade of endogenously released and exogenously administered noradrenaline: Possible relationship to the synaptic location of α 1-and the extrasynaptic location of α 2-adrenoceptors in dog vascular smooth muscle. Br J Pharmacol 72:123P
Leclerc G, Rouot B, Velly J, Schwartz J (1981) β-Adrenergic receptor subtypes. Trends in Pharmacological Sciences 2:18–20
Lee TJF (1977) Sympathetic innervation of rabbit basilar artery: neuromuscular relationship. Fed Proc 36:1036
Lever JD, Mumtazyddin A, Irvine G (1965a) Neuromuscular and intercellular relationship in the coronary arterioles. A morphological and quantitative study by light and electron microscopy. J Anat (London) 99:829–840
Lever JD, Graham JDP, Irvine G, Chick WJ (1965b) The vesiculated axons in relation to arteriolar smooth muscle in the pancreas. A fine structural and quantitative study. J Anat (London) 99:299–313
Levi-Montalcini R (1972) The morphological effects of immunosympathectomy. In: Steiner G, Schönbaum E (eds) Immunosympathectomy. Elsevier, Amsterdam, pp 55–79
Levi-Montalcini R, Angeletti PU (1968) The nerve growth factor. Physiol Rev 48:534–569
Levin JA (1974) The uptake and metabolism of 3H-l-and 3H-dl-norepinephrine by intact rabbit aorta and by isolated adventitia and media. J Pharmacol Exp Ther 190:210–226
Levin JA, Wilson SE (1977) The effect of monoamine oxidase and catechol-O-methyl transferase inhibitors on the accumulation and metabolism of 1-3H-norepinephrine by the adventitia and media of rabbit aorta. J Pharmacol Exp Ther 203:598–609
Limas C, Limas CJ (1978) Reduced number of β-adrenergic receptors in myocardium of spontaneously hypertensive rats. Biochem Biophys Res Commun 83:710–714
Lindmar R, Löffelholz K, Muscholl E (1968) A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibers by nicotinic drugs. Br J Pharmacol 32:280–294
Ljung B (1976) Physiological patterns of neuroeffector control mechanisms. In: Bevan JA, Burnstock G, Johansson B, Maxwell RA, Nedergaard OA (eds) Vascular neuroeffector mechanisms. Karger, Basel, pp 143–155
Ljung B, Bevan JA, Su C (1973) Evidence for uneven alpha-receptor distribution in rat portal vein. Circ Res 32:556–563
Ljung B, Bevan JA, Pegram BL, Purdy RE, Su M (1975) Vasomotor nerve control of isolated arteries and veins. Acta Physiol Scand 94:506–516
Löffelholz K, Muscholl E (1969) A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 265:1–15
Lokhandwala MF, Buckley JP (1976) Effect of presynaptic α-adrenoceptor blockade on responses to cardiac nerve stimulation in anesthetized dogs. Eur J Pharmacol 40:183–186
Lowe MC (1979) Autoradiographic localization of monoamine oxidase in cardiovascular tissues. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: basic and clinical frontiers. Pergamon, New York, pp 1351–1353
Lowe MC, Creveling CR (1979) Immunocytochemical localization of catechol-O-methyltransferase in cardiovascular tissues. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: basic and chemical frontiers. Pergamon, New York, pp 219–221
Mack F, Bönisch H (1979) Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn-Schmiedeberg's Arch Pharmacol 310:1–9
MacMillan WH (1959) A hypothesis concerning the effects of cocaine on the action of sympathomimetic amines. Br J Pharmacol 14:385–391
Madjar H, Docherty JR, Starke K (1980) An examination of pre-and postsynaptic α-adrenoceptors in the autoperfused rabbit hindlimb. J Cardiovasc Pharmacol 2:619–627
Majewski H, Rand MJ (1981) Adrenaline-mediated hypertension: a clue to the antihypertensive effect of β-adrenoceptor blocking drugs? Trends in Pharmacological Sciences 2:24–26
Majewski H, Tung L-H, Rand MJ (1981) Adrenaline-induced hypertension in rats. J Cardiovasc Pharmacol 3:179–185
Marsden CA, Broch OJ Jr, Guldberg HC (1971) Catechol-O-methyltransferase and monoamine oxidase activities in rat submaxillary gland: effects of ligation, sympathectomy and some drugs. Eur J Pharmacol 15:335–342
Maxwell RA, Eckhardt SB, Wastila WB (1968) Concerning the distribution of endogenous norepinephrine in the adventitial and media-intimal layers of the rabbit aorta and the capacity of these layers to bind tritiated norepinephrine. J Pharmacol Exp Ther 161:34–39
Mayer HE, Abboud FM, Ballard DR, Eckstein JW (1968) Catecholamines in arteries and veins of the foreleg of the dog. Circ Res 23:653–661
McCulloch MW, Rand MJ, Story DF (1972) Inhibition of 3H-noradrenaline release from sympathetic nerves of guinea-pig atria by a presynaptic α-adrenoceptor mechanism. Br J Pharmacol 46:523–524P
McCulloch MW, Rand MJ, Story DF (1973) Evidence for dopaminergic mechanisms for modulation of adrenergic transmission in the rabbit ear artery. Br J Pharmacol 49:41P
McGrath MA (1977) 5-Hydroxytryptamine and neurotransmitter release in canine vascular smooth muscle by histamine. Circ Res 41:428–434
McGrath MA, Shepherd JT (1976) Inhibition of adrenergic neurotransmission in canine vascular smooth muscle by histamine. Circ Res 39:566–573
Michel T, Hoffmann BB, Lefkowitz RJ (1980) Differential regulation of the α 2-adrenergic receptors by Na+ and guanine nucleotides. Nature (London) 288:709–711
Minneman KP, Dibner MD, Wolfe PB (1979) β 1-and β 2-adrenergic receptors are independently regulated. Science 204:866–868
Moran NC (1966) Pharmacological characterization of adrenergic receptors. Pharmacol Rev 18:503–512
Moran NC, Perkins ME (1958) Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol. J Pharmacol Exp Ther 124:223–244
Moreira MG, Osswald W (1965) Pronethalol-induced reversal of adrenergic vasodepression. Nature (London) 20:1006–1007
Mukerjee C, Caron MG, Lefkowitz RJ (1975) Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of β-adrenergic receptor binding sites. Proc Natl Acad Sci USA 72:1945–1949
Muldoon SM, Vanhoutte PM, Tyce G (1978) Norepinephrine metabolism in canine saphenous vein: prevalence of glycol metabolites. Am J Physiol 234:H235–H243
Muldoon SM, Tyce GM, Mayer TP, Rorie DK (1979) High pressure liquid chromatographic analysis of endogenous norepinephrine (NE) released from canine saphenous veins. In: Usdin E, Kopin EJ, Barchas J (eds) Catecholamines: basic and clinical frontiers. Pergamon, New York, pp 1488–1490
Muscholl E (1972) Adrenergic false transmitters. In: Blaschko H, Muscholl E (eds) Catecholamines. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 33, pp 618–660)
Nakaki T, Nakada T, Kato R (1980) α 2-Adrenoceptors modulating insulin release from isolated pancreatic islets. Naunyn-Schmiedeberg's Arch Pharmacol 313:151–154
Nedergaard OA, Bevan JA (1971) Neuronal and extraneuronal uptake of adrenergic transmitter in the blood vessel. In: Bevan JA, Fuchgott RF, Maxwell RA, Somlyo AP (eds) Physiology and pharmacology of vascular neuroeffector systems. Karger, Basel, pp 22–34
Nedergaard OA, Schrold J (1977) The mechanism of action of nicotine on vascular adrenergic neuroeffector transmission. Eur J Pharmacol 42:315–329
Nedergaard OA, Schrold J (1980) Effect of neuronal and extraneuronal uptake inhibitors on the fate of 3H-noradrenaline released spontaneously and by electrical field stimulation of rabbit isolated aorta and adventitia. In: Bevan JA, Godfraind T, Maxwell RA, Vanhoutte PM (eds) Vascular neuroeffector mechanisms. Raven, New York, pp 170–176
Nicholas TE, Strum JM, Angelo LS, Junod AF (1974) Site and mechanism of uptake of 3H-l-norepinephrine by isolated perfused rat lungs. Circ Res 35:670–680
Osswald W (1960) Reversal of adrenergic vasodepression. Arch Int Pharmacodyn 126:346–358
Osswald W (1976) Transmitter disposition mechanisms. In: Bevan JA, Burnstock G, Johansson B, Maxwell RA, Nedergaard OA (eds) Vascular neuroeffector mechanisms. Karger, Basel, pp 123–130
Osswald W (1978) Disposition of vasoconstrictor agonists. In: Vanhoutte PM, Leusen I (eds) Mechanisms of vasodilatation. Karger, Basel, pp 89–97
Osswald W (1979) Inactivation of the sympathetic neurotransmitter (in Portuguese). Bol Soc Port Cardiol 17 [Suppl 2]:399–407
Osswald W, Branco D (1973) The effects of drugs and denervation on removal and accumulation of noradrenaline in the perfused hind-limb of the dog. Naunyn-Schmiedeberg's Arch Pharmacol 277:175–190
Osswald W, Guimarães S, Coimbra A (1971) The termination of action of catecholamines in the isolated venous tissue of the dog. Naunyn-Schmiedeberg's Arch Pharmacol 269:15–31
Osswald W, Garrett J, Guimarães S (1975) Extraneuronal uptake and metabolism in dog vascular structures. In: Tuomisto J, Paasonen K (eds) Proceedings 6th International Congress Pharmacology, vol 2 (Neurotransmission), Helsinki, pp 149–158
Owman C (1964) Sympathetic nerves probably storing two types of monoamines in the rat pineal gland. Int J Neuropharmacol 3:105–112
Owman C, Edvinsson L, Hardebo JE (1980) Amine mechanisms and contractile properties of the cerebral microvascular endothelium. In: Bevan JA, Godfraind T, Maxwell RA, Vanhoutte PM (eds) Vascular neuroeffector mechanisms. Raven, New York, pp 277–290
Paiva MQ, Guimarães S (1976) Influence of blockade of extraneuronal uptake on the affinity of some amines for the β-adrenergic receptors of guinea-pig trachea and atria. Arch Farmacol Toxicol 2:185–192
Paiva MQ, Guimarães S (1978) A comparative study of the uptake and metabolism of noradrenaline and adrenaline by the isolated saphenous vein of the dog. Naunyn-Schmiedeberg's Arch Pharmacol 303:221–228
Paiva MQ, Guimarães S (1980) The oil immersion technique for studying the disposition of drugs inducing relaxation: influence of U-0521 and hydrocortisone on the disposition of isoprenaline. J Pharm Pharmacol 32:868–869
Pascual R, Bevan JA (1978) Characteristics of contractile response of rabbit aorta strip to norepinephrine entering through the adventitia and through the intima. Proc West Pharmacol Soc 21:95–98
Pascual R, Bevan JA (1980) Evidence that changes in vascular tone may be initiated from the intima of the rabbit aorta. In: Bevan JA, Godfraind T, Maxwell RA, Vanhoutte PM (eds) Vascular neuroeffector mechanisms. Raven, New York, pp 300–304
Paton DM (1973) Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit aorta. Br J Pharmacol 49:614–627
Paton DM (1976a) Characteristics of uptake of noradrenaline by adrenergic neurons. In: Paton DM (ed) The mechanism of neuronal and extraneuronal transport of catecholamines. Raven, New York, pp 49–66
Paton DM (1976b) Characteristics of efflux of noradrenaline from adrenergic neurons. In: Paton DM (ed) The mechanism of neuronal and extraneuronal transport of catecholamines. Raven, New York, pp 155–174
Paton DM (1979) Release induced by alterations in extracellular potassium and sodium and by veratridine and scorpion venom. In: Paton DM (ed) The release of catecholamines from adrenergic neurons. Pergamon, New York, pp 321–332
Paton WDM (1960) Discussion. In: Vane JR, Wolstenholme GEW, O'Connor M (eds) Ciba Foundation Symposium on catecholamines. Churchill, London, pp 124–127
Pluchino S, Trendelenburg U (1968) The influence of denervation and of decentralization on the alpha and beta effects of isoproterenol on the nictitating membrane of the pithed cat. J Pharmacol Exp Ther 163:257–265
Powell CE, Slater IH (1958) Blocking of inhibitory adrenergic receptors by a dichloro analogue of isoproterenol. J Pharmacol Exp Ther 122:480–488
Powis G (1973) Binding of catecholamines to connective tissue and the effect upon the responses of blood vessels to noradrenaline and to nerve stimulation. J Physiol (London) 234:145–162
Rabin RA, Wolfe BB, Dibner MD, Zahniser NR, Melchior C, Molinoff PB (1980) Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. J Pharmacol Exp Ther 213:491–496
Rand MJ, Story DF, Allen GS, Glover AB, McCulloch MW (1973) Pulse-to-pulse modulation of noradrenaline release through a prejunctional α-receptor auto-inhibitory mechanism. In: Usdin E, Snyder S (eds) Frontiers in catecholamine research. Pergamon, New York, pp 579–581
Rand MJ, McCulloch MW, Story DF (1975) Pre-junctional modulation of noradrenergic transmission by noradrenaline, dopamine and acetylcholine. In: Davies DS, Reid JL (eds) Control action of drugs in blood pressure regulation. Pitman Medical London, pp 94–132
Rand MJ, Law M, Story DF, McCulloch MW (1976) Effects of β-adrenoceptor blocking drugs on adrenergic transmission. Drugs 11 [Suppl 1]:134–143
Rand MJ, Majewski H, McCulloch MW, Story DF (1980) An adrenaline-mediated positive feedback loop in sympathetic transmission and its possible role in hypertension. In: Langer SZ, Starke K, Dubocovich ML (eds) Presynaptic receptors. Pergamon, New York, pp 263–269
Rhodin JAG (1967) The ultrastructure of mammalian arterioles and precapillary sphincters. J Ultrastr Res 18:181–223
Rhodin JAG (1968) Ultrastructure of mammalian venous capillaries, venules, and small collecting veins. J Ultrastr Res 25:452–500
Rosell S, Belfrage E (1975) Adrenergic receptors in adipose tissue and their relation to adrenergic innervation. Nature (London) 253:738–739
Ross G (1976) Adrenergic responses of the coronary vessels. Circ Res 39:461–465
Ruffolo R, Yaden E, Waddel E (1980) Receptor interaction of imidazolines. V. Clonidine differentiates alpha adrenergic receptor subtypes in tissues from the rat. J Pharmacol Exp Ther 213:557–561
Russell MP, Moran NC (1980) Evidence for lack of innervation of β 2-adrenoceptors in the blood vessels of the gracilis muscle of the dog. Circ Res 46:344–352
Salt PJ, Iversen LL (1973) Catecholamine uptake sites in the rat heart after 6-hydroxy-dopamine treatment and in a genetically hypertensive strain. Naunyn-Schmiedeberg's Arch Pharmacol 279:381–386
Salzman EW, Neri LL (1969) Cyclic 3′,5′-adenosine monophosphate in human blood platelets. Nature (London) 224:609–610
Sammet S, Graefe K-H (1979) Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: kinetic evidence for co-transport. Naunyn-Schmiedeberg's Arch Pharmacol 309:99–107
Schrold J, Nedergaard OA (1976) 3H-noradrenaline outflow induced from isolated adventitia and intima-media of rabbit aorta by electrical-field stimulation. Eur J Pharmacol 39:423–427
Schrold J, Nedergaard OA (1977) Neuronal and extraneuronal outflow of 3H-noradrenaline induced by electrical field stimulation of an isolated blood vessel. Acta Physiol Scand 101:129–143
Schrold J, Nedergaard OA (1981) Effect of cocaine and corticosterone on the metabolism of 3H-noradrenaline released from rabbit isolated aorta and adventitia. Acta Pharmacol Toxicol 48:233–241
Shepherd JT, Vanhoutte PM (1975) Veins and their control. Saunders, London
Simpson FO, Devine CE (1966) The fine structure of autonomic neuromuscular contacts in arterioles of sheep renal cortex. J Anat (London) 100:127–137
Smith AD (1973) Mechanisms involved in the release of noradrenaline from sympathetic nerves. In: Iversen LL (ed) Catecholamines. Br Med Bull 29:123–129
Smith AD, Winkler H (1972) Fundamental mechanisms in the release of catecholamines. In: Blaschko H, Muscholl E (eds) Catecholamines. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 33, pp 538–617)
Somlyo AP, Somlyo AV (1968) Vascular smooth muscle. I. Normal structure, pathology, biochemistry and biophysics. Pharmacol Rev 20:197–273
Somlyo AP, Somlyo AV (1970) Vascular smooth muscle. II. Pharmacology of normal and hypertensive vessels. Pharmacol Rev 22:249–353
Spector S, Tarver J, Berkowitz B (1972) Effects of drugs and physiological factors in the disposition of catecholamines in blood vessels. Pharmacol Rev 24:191–202
Speden R (1970) Excitation of vascular smooth muscle. In: Bülbring E, Brading A, Jones A, Tomita T (eds) Smooth muscle. Arnold, London, pp 558–588
Starke K (1971) Influence of α-receptor stimulants on noradrenaline release. Naturwissenschaften 58:420
Starke K (1972) Alpha-sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 274:18–45
Starke K (1977) Regulation of noradrenaline release by presynaptic receptor system. Rev Physiol Biochem Pharmacol 77:1–124
Starke K (1981a) α-Adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 88:199–236
Starke K (1981b) Presynaptic receptors. Ann Rev Pharmacol Toxicol 21:7–30
Starke K, Docherty JR (1980) Recent developments in α-adrenoceptor research. J Cardiovasc Pharmacol 2 [Suppl 3]:S269–286
Starke K, Montel H (1973) Influence of drugs with affinity for alpha-adrenoceptors on noradrenaline release by potassium and tyramine. In: Proceedings 2nd Meeting Adrenergic Mechanisms, University of Porto, Porto, pp 53–54
Starke K, Montel H, Gayk W, Merker R (1974) Comparison of the effects of clonidine on pre-and postsynaptic adrenoceptor in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 285:133–150
Starke K, Borowski E, Endo T (1975a) Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 34:385–388
Starke K, Endo T, Taube HD (1975b) Relative pre-and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 291:55–78
Starke K, Endo T, Taube HD, Borowski E (1975c) Presynaptic receptor systems on noradrenergic nerves. In: Almgren O, Carlsson A, Engel J (eds) Chemical tools in catecholamine research, vol 2. North-Holland, Amsterdam, pp 193–200
Starke K, Steppeler A, Zumsteier A, Henseling M, Trendelenburg U (1980) False labelling of commercially available 3H-catecholamines? Naunyn-Schmiedeberg's Arch Pharmacol 311:109–112
Starke K, Hedler L, Steppeler A (1981) Metabolism of endogenous and exogenous noradrenaline in guinea-pig atria. Naunyn-Schmiedeberg's Arch Pharmacol 317:193–198
Steinsland OS, Furchgott RF, Kirpekar SM (1973) Inhibition of adrenergic neurotransmission by parasympathomimetics in the rabbit ear artery. J Pharmacol Exp Ther 184:346–356
Stene-Larsen G, Helle KB (1978) Cardiac beta2-adrenoceptors in the frog. Comp Biochem Physiol 60:165–173
Steppeler A, Tanaka T, Starke K (1978) A comparison of pre-and postsynaptic α-adrenergic effects of phenylephrine and tramazoline on blood vessels of the rabbit in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 304:223–230
Stevens MJ, Moulds RFW (1982) Are the pre-and postsynaptic α-adrenoceptors in human vascular smooth mucle atypical? J Cardiovasc Pharmacol 4 [Suppl 1]:129–133
Stjärne L (1975) Basic mechanisms and local feedback control of secretion of adrenergic and cholinergic neurotransmitters. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology. Plenum, New York, pp 179–233
Stjärne L, Brundin J (1975) Dual adrenoceptor-mediated control of noradrenaline secretion from human vasoconstrictor nerves: facilitation by β-receptors and inhibition by α-receptors. Acta Physiol Scand 94:139–141
Stjärne L, Gripe K (1973) Prostaglandin-dependent and independent feedback control of noradrenaline secretion in vasoconstrictor nerves of normotensive human subjects. A preliminary report. Naunyn-Schmiedeberg's Arch Pharmacol 280:441–446
Su C (1978) Purinergic inhibition of adrenergic transmission in rabbit blood vessels. J Pharmacol Exp Ther 204:351–361
Su C, Bevan JA (1970) The release of 3H-norepinephrine in arterial strips studied by the technique of superfusion and transmural stimulation. J Pharmacol Exp Ther 172:62–68
Su C, Bevan JA (1971) Adrenergic transmitter release and distribution in blood vessels. In: Bevan JA, Furchgott RF, Maxwell RA, Somlyo AP (eds) Physiology and pharmacology of vascular neuroeffector systems. Karger, Basel, pp 13–21
Sullivan AT, Drew GM (1980) Pharmacological characterization of pre-and post-synaptic α-adrenoceptors in dog saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 314:249–258
Taira N, Yabuuchi Y, Yamashita S (1977) Profile of β-adrenoceptors in femoral, superior mesenteric, and renal vascular beds of dogs. Br J Pharmacol 59:577–583
Takimoto GS, Cho AK, Shaeffer JC (1977) Inhibition of norepinephrine accumulation by amphetamine derivatives. Studies with rat brain and rabbit aorta. J Pharmacol Exp Ther 202:267–277
Tatum AL (1912) On the destruction of epinephrine and constrictory substances of serum by oxygenation in the presence of blood vessel walls. J Pharmacol Exp Ther 4:151–156
Teixeira F (1977) The effects of drugs and denervation on removal and accumulation of adrenaline in the perfused hind-limb of the dog. Arch Int Pharmacodyn 225:221–231
Teixeira F, Macedo TRA (1981) Influence of deaminated metabolites on the relaxing effect of dopamine on dog saphenous vein. J Pharm Pharmacol 33:529–533
Thoenen H (1972) Surgical, immunological and chemical sympathectomy. Their application in the investigation of the physiology and pharmacology of the sympathetic nervous system. In: Blaschko H, Muscholl E (eds) Catecholamines. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 33, p 813)
Thoenen H, Tranzer JP (1971) Functional importance of subcellular distribution of false adrenergic transmitters. Progr Brain Res 34:223–236
Thureson-Klein Å, Stjärne L, Brundin J (1976) Ultrastructure of nerves in veins from human omentum. Neuroscience 1:333–337
Thureson-Klein Å, Klein RK, Stjärne L (1979) Vesicle populations and exocytosis in noradrenergic terminals of human veins. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: basic and clinical frontiers. Pergamon, New York, pp 262–264
Timmermans PBMWM, Kwa HY, van Zwieten PA (1979) Possible subdivision of post-synaptic α-adrenoceptors mediating pressor response in the pithed rat. Naunyn-Schmiedeberg's Arch Pharmacol 310:189–193
Toda N, Goldberg LI (1975) Effects of dopamine on isolated canine coronary arteries. Cardiovasc Res 9:384–389
Török J, Bevan JA (1971) Entry of 3H-norepinephrine into the arterial wall. J Pharmacol Exp Ther 177:613–620
Trendelenburg U (1959) The supersensitivity caused by cocaine. J Pharmacol Exp Ther 125:56–65
Trendelenburg U (1972a) Classification of sympathomimetic amines. In: Blaschko H, Muscholl E (eds) Catecholamines. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 33, pp 336–362)
Trendelenburg U (1972b) Factors influencing the concentration of catecholamines at the receptors. In: Blaschko H, Muscholl E (eds) Catecholamines. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 33, pp 726–761)
Trendelenburg U (1974) The relaxation of rabbit aortic strips after a preceding exposure to sympathomimetic amines. Naunyn-Schmiedeberg's Arch Pharmacol 281:13–46
Trendelenburg U (1978) Extraneuronal uptake and metabolism of catecholamines as a site of loss. Life Sci 22:1217–1222
Trendelenburg U (1979) Release induced by phenethylamines. In: Paton DM (ed) The release of catecholamines from adrenergic neurons. Pergamon, New York, pp 333–354
Trendelenburg U (1980) A kinetic analysis of the extraneuronal uptake and metabolism of catecholamines. Rev Physiol Biochem Pharmacol 87:33–115
Triner L, Vulliemoz Y, Verosky M, Mangor WM (1975) Cyclic adenosine monophosphate and vascular reactivity in spontaneous hypertensive rats. Biochem Pharmacol 24:743–745
Tsunekawa K, Morhri K, Ikeda M, Ohgushi N, Fujiwara M (1967) Histochemical demonstration of adrenergic fibers in the smooth muscle layer of media of dorsal pedal artery in dog. Experientia 23:842–843
U'Prichard DC, Snyder SH (1978) Guanyl nucleotide influence on 3H-ligand binding to alpha-noradrenergic receptors in calf brain membranes. J Biol Chem 253:3444–3452
Vanhoutte PM, Lorenz RR, Tyce GM (1973) Inhibition of norepinephrine-3H-release from sympathetic nerve endings in veins by acetylcholine. J Pharmacol Exp Ther 185:386–394
Vanhoutte PM, Coen EP, de Ridder WJ, Verbeuren TJ (1979) Evoked release of endogenous norepinephrine in the canine saphenous vein. Inhibition by acetylcholine. Circ Res 45:608–614
Vanhoutte PM, Verbeuren TJ, Webb RC (1981) Local modulation of adrenergic neuroeffector interaction in the blood vessel wall. Physiol Rev 61:151–247
Van Meel JCA, De Jonge A, Kalman HO, Wilffert B, Timmermans PBMWM, van Zwieten PA (1981) Vascular smooth muscle contraction initiated by postsynaptic α2-adrenoceptors activation is induced by an influx of extracellular calcium. Eur J Pharmacol 69:205–208
Van Rossum JM (1966) The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn 160:492–494
Verhaege RH, Vanhoutte PM, Shepherd JT (1977) Inhibition of sympathetic neurotransmission in canine blood vessels by adenosine and adenosine nucleotides. Circ Res 40:208–215
Verity MA (1971) Morphologic studies of the vascular neuroeffector apparatus. In: Bevan JA, Furchgott RF, Maxwell RA, Somlyo AP (eds) Physiology and pharmacology of vascular neuroeffector systems. Karger, Basel, pp 2–12
Verity MA, Bevan JA (1968) Fine structural study of the terminal effector plexus, neuromuscular and intermuscular relationships in the pulmonary artery. J Anat (London) 103:49–63
Vizi ES (1979) Presynaptic modulation of neurochemical transmission. Progr Neurobiol 12:181–290
Westfall TC (1977) Local regulation of adrenergic neurotransmission. Physiol Rev 57:660–728
Westfall TC, Peach MJ, Tittermary V (1979) Enhancement of the electrically induced release of norepinephrine from the rat portan vein: mediation by β2-adrenoceptors. Eur J Pharmacol 58:67–74
White FN, Ikeda M, Elsner RW (1973) Adrenergic innervation of large arteries in the seal. Comp Gen Pharmacol 4:271–276
Winquist RJ, Bevan JA (1979) The effect of surgical sympathetic denervation upon the development of intrinsic myogenic tone and the alpha and beta adrenergic receptor-mediated responses of the rabbit facial vein. J Pharmacol Exp Ther 211:1–6
Wood CL, Arnett CD, Clarke WR, Tsai BS, Lefkowitz RJ (1979) Subclassification of alpha-adrenergic receptors by direct binding studies. Biochem Pharmacol 28:1277–1282
Woodcock EA, Funder JW, Johnston CI (1979) Decreased cardiac β-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. Circ Res 45:560–565
Wyse DG (1974) On the role of neuronal uptake (uptake1) in the inactivation of noradrenaline by aortic strips. Can J Physiol Pharmacol 52:1102–1109
Wyse DG (1976) Inactivation of neural and exogenous norepinephrine in rat tail artery by the oil immersion technique. J Pharmacol Exp Ther 198:102–111
Yamaguchi N, De Champlain J, Nadeau RA (1977) Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha and beta receptors. Circ Res 41:108–117
Zuberbuhler RC, Bohr DF (1965) Responses of coronoary smooth muscle to catecholamines. Circ Res 16:431–440
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Verlag
About this chapter
Cite this chapter
Osswald, W., Guimarães, S. (1983). Adrenergic mechanisms in blood vessels: Morphological and pharmacological aspects. In: Reviews of Physiology, Biochemistry and Pharmacology, Volume 96. Reviews of Physiology, Biochemistry and Pharmacology, vol 96. Springer, Berlin, Heidelberg. https://doi.org/10.1007/BFb0031007
Download citation
DOI: https://doi.org/10.1007/BFb0031007
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-11849-7
Online ISBN: 978-3-540-39499-0
eBook Packages: Springer Book Archive